Sir, now that Roche\'s SARS-CoV-2 antibody test has been approved by Public Health England, might it be reasonable for dental practice generally and SDCEP in particular to take this into consideration?

A patient who has tested positive could be viewed as reasonably safe for AGPs, with normal PPE. I do understand that we have a lot still to learn, but we need some decent working hypotheses. In the larger picture, we might be able to help roll out broader testing, take the load off our medical colleagues and help the public and especially the NHS and carers get back to work safely. This is in line with Scottish Government policy.^[@CR24622]^

Dental patients could also be tested on their examination appointment by the dentist; results are rapid and follow up could be quickly organised to book positive patients in for AGPs. Dentists will need some phlebotomy training. Many of us have experience in this but may need updating and being taught the specific requirements of the Elecsys Anti-SARS-CoV-2 serology test; others do not have such experience and will need a somewhat more extended course. Perhaps the practicalities of such training could be investigated by NES.

In Scotland a mechanism for reimbursement already exists within the SDR; 3601 - Taking of material for pathological examination: per course of treatment £14.00 (£11.20). This would be a good mechanism for reporting results via practitioners\' services, to the wider NHS and researchers. I imagine that the fee would be about right for the practice, but that the test itself would be funded through local pathology services. The implementation of this is within the gift of practitioner services or failing that the CADO or failing him, the minister. At the moment, while we are on \'benefits\' it would cost the treasury nothing.

It is a little distressing that private companies (like Sodexo at Edinburgh Airport) have been given public funds to do antigen testing, while dentists are sitting at home and currently being supported by the NHS, when they could be doing this work.
